Average Co-Inventor Count = 7.98
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-Myers Squibb Compnay (37 from 3,685 patents)
2. Bristol-Myers Squibb Pharma Company (234 patents)
37 patents:
1. 12365667 - Sulfone pyridine alkyl amide-substituted heteroaryl compounds
2. 12037323 - Uracil derivatives as Mer-AXL inhibitors
3. 11787779 - Sulfone pyridine alkyl amide-substituted heteroaryl compounds
4. 11713316 - Substituted naphthyridinone compounds useful as T cell activators
5. 11021462 - Sulfone pyridine alkyl amide-substituted heteroaryl compounds
6. 10954238 - Substituted naphthyridinone compounds useful as T cell activators
7. 10669272 - Substituted naphthyridinone compounds useful as T cell activators
8. RE47929 - Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses
9. 10273237 - Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN-α responses
10. 10196387 - Carbazole compounds useful as bromodomain inhibitors
11. 10112941 - Tricyclic compounds as anticancer agents
12. 10053454 - Carbazole compounds useful as bromodomain inhibitors
13. 10000480 - Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
14. 9987266 - Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses
15. 9751879 - Tricyclic compounds as anticancer agents